EFFECT OF CYCLOSPORINE TIME IN THERAPEUTIC RANGE ON CELLULAR REJECTION IN 1 YEAR AFTER HEART TRANSPLANTATIO

Completed

• Conditions: This was a single-center retrospective cohort study. Adult HTRs at King Chulalongkorn Memorial Hospital (KCMH) between January 1, 2009, and December 31, 2021, who were maintained on CsA within the first year of HT were analyzed.; Heart transplantation; Cyclosporine; Acute cellular rejection

• Registration Number: TCTR20240319005
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-04-30
• Study Start: 2024-03-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

This was a single-center retrospective cohort study. Adult HTRs at King Chulalongkorn Memorial Hospital (KCMH) between January 1, 2009, and December 31, 2021, who were maintained on cyclosporine within the first year of HT were analyzed.

Exclusion Criteria

Recipients who were initial calcineurin inhibitors other than CsA, combined heart and other organ transplant, with organ transplant history, were excluded

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acute cellular rejection 1 year Time to event

Secondary Outcome Measures

Name	Time	Method
n/a n/a n/a